HeartBeam, Inc.(BEAT)

Medical - Specialties · Santa Clara, CA

$0.60-0.05 (-7.67%)

Delayed quote: Oct 6, 2026, 10:15 AM EDT

Price/OCF Ratio: N/A

Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/OCF ratio is N/A as of 2026-10-06T14:15:52.706Z.

Stored calculation inputs

Calculation as of: 2026-10-06T14:15:52.706Z.

Quote observation: 2026-10-06T14:15:24.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 33,526,129
TTM operating cash flow · period ending 2026-06-30: -13,018,000

FMP input reference: a5ea7848df566bb1fba137e14a23bd7a424b67da13a14cf2752e181034030ce3

P/E Ratio|P/FCF Ratio|Operating Cash Flow|Operating Margin|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

BEAT Price/OCF Ratio Metrics

PRICE/OCF RATIO

N/A

BEAT Competitors' Price/OCF Ratio

BEAT

HeartBeam, Inc.

Current

Market Cap

$33.53M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

EUDA

EUDA Health Holdings Limited

vs BEAT

Market Cap

$33.24M

Price/OCF Ratio

N/A

TTM Avg

503.18

3Y Avg

503.18

5Y Avg

503.18

ALGS

Aligos Therapeutics, Inc.

vs BEAT

Market Cap

$32.86M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GRCE

Grace Therapeutics, Inc.

vs BEAT

Market Cap

$34.01M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CNTX

Context Therapeutics Inc.

vs BEAT

Market Cap

$32.06M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MIRA

MIRA Pharmaceuticals, Inc.

vs BEAT

Market Cap

$31.62M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BYSI

BeyondSpring Inc.

vs BEAT

Market Cap

$31.46M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BDMD

Baird Medical Investment Holdings Limited

vs BEAT

Market Cap

$31.19M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BCTX

BriaCell Therapeutics Corp.

vs BEAT

Market Cap

$35.58M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MDXH

MDxHealth S.A.

vs BEAT

Market Cap

$31.10M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PRICE/OCF RATIO	TTM	3Y	5Y
HeartBeam, Inc. (BEAT)	$33.53M	N/A	N/A	N/A	N/A
EUDA Health Holdings Limited (EUDA)vs ›	$33.24M	N/A	503.18	503.18	503.18
Aligos Therapeutics, Inc. (ALGS)vs ›	$32.86M	N/A	N/A	N/A	N/A
Grace Therapeutics, Inc. (GRCE)vs ›	$34.01M	N/A	N/A	N/A	N/A
Context Therapeutics Inc. (CNTX)vs ›	$32.06M	N/A	N/A	N/A	N/A
MIRA Pharmaceuticals, Inc. (MIRA)vs ›	$31.62M	N/A	N/A	N/A	N/A
BeyondSpring Inc. (BYSI)vs ›	$31.46M	N/A	N/A	N/A	N/A
Baird Medical Investment Holdings Limited (BDMD)vs ›	$31.19M	N/A	N/A	N/A	N/A
BriaCell Therapeutics Corp. (BCTX)vs ›	$35.58M	N/A	N/A	N/A	N/A
MDxHealth S.A. (MDXH)vs ›	$31.10M	N/A	N/A	N/A	N/A

Operating Cash Flow Valuation

P/OCF Ratio

N/A

P/FCF Ratio

N/A

Price/OCF Ratio Formula & Definition

P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Price/OCF Ratio: N/A

BEAT Price/OCF Ratio Metrics

BEAT Competitors' Price/OCF Ratio

Operating Cash Flow Valuation

Price/OCF Ratio Formula & Definition

Related Metrics